Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
205.80 |
175.20 |
186.30 |
217.40 |
199.84 |
Operating profit |
12.20 |
-0.70 |
0.80 |
4.20 |
2.18 |
Interest |
8.10 |
8.30 |
7.10 |
6.40 |
5.70 |
Gross profit |
54.20 |
10.00 |
12.10 |
13.70 |
10.14 |
EPS (Rs) |
2.04 |
-0.15 |
-0.03 |
0.12 |
-1.94 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
50.10 |
19.00 |
18.40 |
15.90 |
13.66 |
Stock adjustment |
19.30 |
-1.20 |
-10.30 |
31.20 |
12.58 |
Raw material |
74.10 |
69.10 |
94.90 |
71.90 |
90.39 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
46.50 |
49.90 |
46.10 |
47.50 |
40.07 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
53.70 |
58.10 |
54.80 |
62.60 |
54.62 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
12.70 |
12.30 |
11.90 |
11.40 |
11.37 |
Taxation |
9.00 |
0.10 |
0.60 |
0.40 |
29.63 |
Net profit / loss |
32.50 |
-2.40 |
-0.40 |
1.90 |
-30.86 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.90 |
15.90 |
15.90 |
15.90 |
15.93 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
5.93 |
-0.40 |
0.43 |
1.93 |
1.09 |
GPM (%) |
21.18 |
5.15 |
5.91 |
5.87 |
4.75 |
NPM (%) |
12.70 |
-1.24 |
-0.20 |
0.81 |
-14.45 |